Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 1:13:1115-1122.
doi: 10.2147/OPTH.S184412. eCollection 2019.

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease

Rodrigo Carlos de Oliveira  1 , Steven E Wilson  1
Affiliations

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease

Rodrigo Carlos de Oliveira et al. Clin Ophthalmol. .

Abstract

Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) improves the treatment outcomes of most patients with DED. The purpose of this review is to provide guidance for practitioners in the use of topical CsA for the management of DED to improve patient satisfaction and the quality of life.

Keywords: cyclosporine A; dry eye disease; keratoconjunctivitis sicca.

PubMed Disclaimer

Conflict of interest statement

SEW was a consultant for Allergan in developing and implementing the phase III clinical trials for Restasis. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Dry eye disease (DED) management strategy. Data from Jones et al (2017).
See this image and copyright information in PMC

References

    1. Dana R, Bradley JL, Guerin A, et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States health care system. Am J Ophthalmol. 2019;202:47–54. - PubMed
    1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi: 10.1016/j.jtos.2017.05.003 - DOI - PubMed
    1. Epidemiology DEWS subcommittee. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5(2):93–107. doi: 10.1016/S1542-0124(12)70082-4 - DOI - PubMed
    1. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi: 10.1016/j.jtos.2017.05.008 - DOI - PubMed
    1. McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf. 2016;14(2):144–167. doi: 10.1016/j.jtos.2015.11.002 - DOI - PubMed

LinkOut - more resources